Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
ASACOL |
| Manufacturer |
|
Procter & Gamble Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Salicylate. |
| Generic Name |
|
Mesalamine 400mg; delayed release tabs. |
| Indications |
|
Ulcerative colitis. |
| Children |
|
Not recommended. |
| Adults |
|
Do not crush or chew. Treatment: 800mg 3 times daily for 6 weeks. Maintenance: 1.6 g/day in divided doses. |
| Precautions |
|
Pyloric stenosis. History of renal disease; monitor renal function before and during therapy. Reevaluate periodically. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Exacerbation of symptoms (discontinue if occurs), renal toxicity, GI upset or pain, constipation, arthralgia, myalgia, GI bleed, rhinitis, pharyngitis, vasodilation, ear or visual disturbances, infection, others. |
| How Supplied |
|
Tabs—100 |
|
|
|
|
